Christel C L M Boons

6PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)NanomedicineHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2020
Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib.

Christel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen

|Apr 04, 2020
Food-effect study of nilotinib in chronic myeloid leukaemia (NiFo study): Enabling dose reduction and relief of treatment burden.

Christel C L M Boons, Yvonne M den Hartog, Jeroen J W M Janssen

|Feb 08, 2019
Feasibility of and patients' perspective on nilotinib dried blood spot self-sampling.

Christel C L M Boons, Lonneke Timmers, Jeroen J W M Janssen

|Jul 31, 2018
Needs for information and reasons for (non)adherence in chronic myeloid leukaemia: Be aware of social activities disturbing daily routines.

Christel C L M Boons, Lorette Harbers, Lonneke Timmers

|Nov 24, 2017
Patient satisfaction with information on oral anticancer agent use.

Christel C L M Boons, Lonneke Timmers, Natasja M van Schoor

|Jun 24, 2017
Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.

Christel C L M Boons, Abdel Chahbouni, Anneliene M Schimmel

Pageof 1

Frequent Collaborators